Loading…
Marks & Clerk
Manufacturing-IP focusActive litigationLeading International Intellectual Property Firm
About
Marks & Clerk is an international intellectual property firm which states it "set up its first office in the UK in 1887" and today reports "300 practitioners around the world" and "15 offices across three continents". The firm states it brings together "patent attorneys, trade mark attorneys, commercial lawyers and IP litigators" and provides "every type of intellectual property service from the moment an invention is identified through to enforcement or defence of IP rights in opposition proceedings or litigation". Life Sciences is one of its named sectors, alongside Chemistry, Medical Technologies, Agritech, Digital Transformation, Energy & Environment and others.
Strategic positioning
European prosecution and opposition strength across biologics and pharmaceutical chemistry.
Deterministic scores · rules-based, not AI iHow these scores are obtained: each one is computed from this profile's listed attributes — capability checkboxes, certifications, capacity figures and coverage — by a fixed formula, recomputed on every page load. Deterministic and rules-based means the score comes from a fixed, transparent formula over listed attributes — the same inputs always produce the same score. It is not AI: there is no model, no learning, and no hidden weighting. Whether a score is relevant to you depends on your specific project: a capability that raises the number may not matter for your work, and a niche strength your project needs may barely move it. Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Manufacturing-IP focus iAdds 25 points if the firm declares a manufacturing-IP focus, plus 9 points per manufacturing technology area listed (sterile injectables, biologics, radiopharmaceuticals, biosimilars, drug-device combinations, mRNA/LNP), capped at 45, plus 8 points per manufacturing-IP service (CMC patents, trade secret governance, FTO opinions, patent term extension), capped at 30. Levels: 75+ Manufacturing-IP specialist | 50-74 Manufacturing-active | 25-49 Selective | below 25 Therapeutics-IP focused. Whether this dimension matters for you depends on your specific project.
59Manufacturing-active
Life-sciences IP iAdds 4 points per technology area, capped at 30, plus 5 points per practice area, capped at 25, plus 4 points per jurisdiction, capped at 20, plus up to 25 points for technical depth based on the share of attorneys holding PhDs or advanced degrees. Levels: 80+ Premier life-sciences IP | 60-79 Strong | 40-59 Established | below 40 Emerging. Whether this dimension matters for you depends on your specific project.
61Strong
Patent portfolio iAdds 3 points per patent on the platform, capped at 30, plus up to 25 points for the share that are granted, litigated, or opposed, plus 3 points per unique jurisdiction covered, capped at 25, plus up to 20 points from the average per-patent valuation score. Shows 0 with No portfolio when no patents are listed. Levels: 75+ Robust portfolio | 55-74 Solid | 35-54 Developing | below 35 Thin. Whether this dimension matters for you depends on your specific project.
53Developing
Protection strength iAdds 5 points per exclusivity record, capped at 30, plus up to 20 points for the share with active status, plus 7 points per distinct regulatory agency, capped at 20, plus up to 30 points for the average years until loss of exclusivity (the later of patent and regulatory expiry), maxing out at 12 years. Shows 0 with No exclusivities when none are listed. Levels: 75+ Strongly protected | 55-74 Well protected | 35-54 Moderate | below 35 Exposed. Whether this dimension matters for you depends on your specific project.
55Well protected
Technology areas
BiologicsSmall moleculesSterile injectablesMedical devicesDiagnostics
Practice areas
Patent prosecutionEPO oppositionFreedom-to-operate (FTO)Patent portfolio strategyTrademark
Jurisdictions
EPOUKIPOWIPO / PCTGermany (DPMA)
M&
Marks & Clerk
IP & patent counsel · United Kingdom
Live record · illustrative seed data · scores deterministic, rules-based — not AI.